Drug
BI 695501 clinical trials
Also written BI 695501.
A product of Adalimumab; its studies count on that page too.
- studies test it
- 9
- open now
- 0
- in phase 3
- 4
- first study started
- 2011
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
9 studies that test it; most in 2016 (3)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 1
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 0
Studies
Open first, then newest update. How each study uses BI 695501 is read from its arms, and is right about nine times in ten.
Testing it · 9
- A Study in Healthy People to Test How 2 Different Formulations of BI 695501 Are Taken up by the Body When Given as an InjectionCompletedPhase 1Boehringer IngelheimNCT05203289Written as BI 695501 - higher concentration
- The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque PsoriasisCompletedPhase 3Boehringer IngelheimNCT03210259Written as BI 695501
- Pharmacokinetics and Safety Study of BI 695501 in Healthy SubjectsCompletedPhase 1Boehringer IngelheimNCT01505491Written as BI695501
- Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedPhase 3Boehringer IngelheimNCT02850965Written as BI 695501
- Pharmacokinetics and Safety of BI 695501 Administered Via Prefilled Syringe or AutoinjectorCompletedPhase 1Boehringer IngelheimNCT02606903Written as BI 695501 prefilled syringe
- Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid ArthritisCompletedPhase 3Boehringer IngelheimNCT02640612Written as BI 695501
- Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled SyringeCompletedPhase 2Boehringer IngelheimNCT02636907Written as BI 695501 Autoinjector
- Pharmacokinetics and Safety in Healthy VolunteersCompletedPhase 1Boehringer IngelheimNCT02045979Written as BI 695501
- BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid ArthritisCompletedPhase 3Boehringer IngelheimNCT02137226Written as BI 695501